head and neck cancer

Flexibility and adaptation concept Arrows on cubes following a flexible path

Biotech

'One of the lucky few': Bicara CEO on last year's $326M IPO

“We continue to operate as if we're in a world where financings are hard to achieve,” CEO Claire Mazumdar said after Bicara's $362 million 2024 IPO.

Gabrielle Masson Apr 14, 2025 3:59pm

White arrow on a road pointing to the rising sun

Avacta hits 10% response rate, adds peptide-drug conjugate arms

Jan 16, 2025 8:51am

An arrow incrementally going up stairs before pointing straight up Blue background

Merus touts cancer drug's strong profile with new data drop

Dec 2, 2024 11:59am

share price stock stock price shares falling falling

Pyxis' shares fall on lukewarm early ADC results in solid tumors

Nov 21, 2024 2:30pm

Graphic showing arrows missing the bullseye on a target

Ultimovacs cancer vaccine fails again, enters last chance saloon

Aug 6, 2024 4:14am

step up climb ladder sky hang on rung

Immutep regains pep as cancer subgroup data show path forward

Jul 12, 2024 9:35am